Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

The Czech Surveillance System for Invasive Pneumococcal Disease, 2008-2013: A Follow-Up Assessment and Sensitivity Estimation

NK. Stock, M. Maly, H. Sebestova, H. Orlikova, J. Kozakova, P. Krizova,

. 2015 ; 10 (6) : e0131117. [pub] 20150630

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc16020608

BACKGROUND: Invasive pneumococcal disease (IPD) is caused by Streptococcus pneumoniae and mostly presents as pneumonia, sepsis or meningitis. A notable portion of IPD cases is vaccine preventable and the pneumococcal conjugate vaccine (PCV) was introduced into the routine childhood immunization programs in many countries during the last decades. OBJECTIVES: Before PCV introduction in the Czech Republic in 2010, a national surveillance system for IPD was implemented in 2008 and further improved in 2011. In this study, we describe the new surveillance system for the first time and measure its sensitivity between 2010 and 2013 using the capture-recapture method. Furthermore, we describe the recent epidemiological trend of IPD, taking sensitivity estimates into account. RESULTS AND CONCLUSIONS: Between 2010 and 2013 the estimated sensitivity of the overall IPD surveillance increased from 81% to 99%. The sensitivity of individual reporting sources increased from 72% to 87% for the laboratory system and from 31% to 89% for the epidemiological notification system. Crucial for this improvement was the introduction of quarterly report reminders in 2011. Due to positive source dependency, the presented sensitivity estimates are most probably overestimated and reflect the upper limit of reporting completeness. Stratification showed variation in sensitivity of reporting particularly according to region. An effect of the PVC vaccination in the Czech Republic is visible in the incidence of IPD in target age groups (<5 y). This influence was not evident in the total IPD incidence and may interfere with increasing sensitivity of reporting. In 2013, an increase in the IPD incidence was observed. This finding requires further observation and a detailed vaccine impact analysis is needed to assess the current immunization strategy.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc16020608
003      
CZ-PrNML
005      
20171116131029.0
007      
ta
008      
160722s2015 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1371/journal.pone.0131117 $2 doi
024    7_
$a 10.1371/journal.pone.0131117 $2 doi
035    __
$a (PubMed)26125583
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Stock, Nina Katharina $u National Institute of Public Health (NIPH), Prague, Czech Republic; European Program for Public Health Microbiology (EUPHEM), ECDC, Stockholm, Sweden.
245    14
$a The Czech Surveillance System for Invasive Pneumococcal Disease, 2008-2013: A Follow-Up Assessment and Sensitivity Estimation / $c NK. Stock, M. Maly, H. Sebestova, H. Orlikova, J. Kozakova, P. Krizova,
520    9_
$a BACKGROUND: Invasive pneumococcal disease (IPD) is caused by Streptococcus pneumoniae and mostly presents as pneumonia, sepsis or meningitis. A notable portion of IPD cases is vaccine preventable and the pneumococcal conjugate vaccine (PCV) was introduced into the routine childhood immunization programs in many countries during the last decades. OBJECTIVES: Before PCV introduction in the Czech Republic in 2010, a national surveillance system for IPD was implemented in 2008 and further improved in 2011. In this study, we describe the new surveillance system for the first time and measure its sensitivity between 2010 and 2013 using the capture-recapture method. Furthermore, we describe the recent epidemiological trend of IPD, taking sensitivity estimates into account. RESULTS AND CONCLUSIONS: Between 2010 and 2013 the estimated sensitivity of the overall IPD surveillance increased from 81% to 99%. The sensitivity of individual reporting sources increased from 72% to 87% for the laboratory system and from 31% to 89% for the epidemiological notification system. Crucial for this improvement was the introduction of quarterly report reminders in 2011. Due to positive source dependency, the presented sensitivity estimates are most probably overestimated and reflect the upper limit of reporting completeness. Stratification showed variation in sensitivity of reporting particularly according to region. An effect of the PVC vaccination in the Czech Republic is visible in the incidence of IPD in target age groups (<5 y). This influence was not evident in the total IPD incidence and may interfere with increasing sensitivity of reporting. In 2013, an increase in the IPD incidence was observed. This finding requires further observation and a detailed vaccine impact analysis is needed to assess the current immunization strategy.
650    _2
$a biostatistika $7 D056808
650    _2
$a epidemiologické monitorování $7 D062665
650    _2
$a následné studie $7 D005500
650    _2
$a lidé $7 D006801
650    _2
$a očkovací programy $x statistika a číselné údaje $7 D017589
650    _2
$a očkovací schéma $7 D007115
650    _2
$a incidence $7 D015994
650    _2
$a hromadná vakcinace $x statistika a číselné údaje $7 D032541
650    _2
$a programy národního zdraví $x statistika a číselné údaje $7 D009313
650    _2
$a pneumokokové infekce $x epidemiologie $x prevence a kontrola $7 D011008
650    _2
$a pneumokokové vakcíny $x aplikace a dávkování $7 D022242
650    _2
$a vakcíny konjugované $x aplikace a dávkování $7 D018074
651    _2
$a Česká republika $x epidemiologie $7 D018153
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Maly, Marek $u National Institute of Public Health (NIPH), Prague, Czech Republic.
700    1_
$a Sebestova, Helena $u National Institute of Public Health (NIPH), Prague, Czech Republic.
700    1_
$a Orlíková, Hana, $d 1965- $7 xx0218806 $u National Institute of Public Health (NIPH), Prague, Czech Republic.
700    1_
$a Kozakova, Jana $u National Institute of Public Health (NIPH), Prague, Czech Republic.
700    1_
$a Krizova, Pavla $u National Institute of Public Health (NIPH), Prague, Czech Republic.
773    0_
$w MED00180950 $t PloS one $x 1932-6203 $g Roč. 10, č. 6 (2015), s. e0131117
856    41
$u https://pubmed.ncbi.nlm.nih.gov/26125583 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20160722 $b ABA008
991    __
$a 20171116131141 $b ABA008
999    __
$a ok $b bmc $g 1155278 $s 945136
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2015 $b 10 $c 6 $d e0131117 $e 20150630 $i 1932-6203 $m PLoS One $n PLoS One $x MED00180950
LZP    __
$a Pubmed-20160722

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...